{
  "id": "2310515829d953ce",
  "title": "Analyst Bullish on Beam Therapeutics ( BEAM ) Over Drug Program Trajectory",
  "description": "20260219T011500Z",
  "content": "",
  "source": "insidermonkey.com",
  "source_url": "https://www.insidermonkey.com/blog/analyst-bullish-on-beam-therapeutics-beam-over-drug-program-trajectory-1698374/",
  "published_at": "20260219T011500Z",
  "fetched_at": "2026-02-20T00:27:32.210173+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.insidermonkey.com/blog/analyst-bullish-on-beam-therapeutics-beam-over-drug-program-trajectory-1698374/",
    "url_mobile": "https://www.insidermonkey.com/blog/analyst-bullish-on-beam-therapeutics-beam-over-drug-program-trajectory-1698374/?amp=1",
    "title": "Analyst Bullish on Beam Therapeutics ( BEAM ) Over Drug Program Trajectory",
    "seendate": "20260219T011500Z",
    "socialimage": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2026/02/13233136/pexels-polina-tankilevitch-5234505.jpg",
    "domain": "insidermonkey.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}